Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.
- NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_assertion description "[It may be possible to determine the appropriate CY dose in the preconditioning regimen for SCT in FA patients on the basis of the in vitro effects on fragility, and Flu or Ara-C may be a safer drug than high-dose CY for conditioning in FA patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.
- NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_assertion evidence source_evidence_literature NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.
- NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_assertion SIO_000772 17483082 NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.
- NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_assertion wasDerivedFrom befree-20140225 NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.
- NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_assertion wasGeneratedBy ECO_0000203 NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP731082.RADKoGRNwMRI_Cr34iQy6zBWbwdzFsiEvKSqxmSbRl3nY130_provenance.